Placebo News and Research

RSS

Trial of early antiviral therapy for COVID-19 shows no significant benefit

A new preprint research paper examines the efficacy of using three antivirals in various combinations in early infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Two doses of psilocybin may ease depression symptoms for up to 12 months

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month.

15 Feb 2022

New approach to alter the skin microbiome and reduce acne lesions using bacteria

Acne on the face is often treated with topical antibiotics, which tend to be used for an extended period of time and contribute to the serious problem of antibiotic resistance.

15 Feb 2022

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

A recent study posted to the medRxiv* preprint server reported the phase one pharmacokinetic and safety data of nirmatrelvir/ritonavir to facilitate its rapid progression to the last stages of clinical trials in coronavirus disease 2019 (COVID-19) patients with mild to moderate disease.

14 Feb 2022

Individuals with alcohol problems may have lower functional connectivity in brain regions that process emotions

People predisposed to heavy drinking and alcohol problems may have lower functional connectivity - the patterns of signaling between brain areas - in regions that process emotions and social situations.

10 Feb 2022

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under 5 on an emergency basis, with the possibility for a third.

9 Feb 2022

Study examines whether viagra-like drug may be effective in treating vascular dementia

A new study, published today in Alzheimer's & Dementia, tested whether tadalafil, a drug closely related to Viagra, may be effective in treating people with vascular dementia.

9 Feb 2022

Reanalysis of the efficacy of COVID-19 vaccines

In a new study, researchers investigated the impact of trial study design and other parameters on the estimates of COVID-19 vaccine efficacy.

8 Feb 2022

Paracetamol use increases blood pressure, study shows

Long-term paracetamol use could increase the risk of heart disease and strokes in people with high blood pressure, a study suggests.

7 Feb 2022

Two peanut allergy treatments for children found to be highly effective at inducing remission

Researchers have discovered two peanut allergy treatments for children that are both highly effective at inducing remission.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

In a new study, a team of researchers assessed the efficacy of booster doses of Ad26.COV2.S (Jansen) SARS-CoV-2 vaccine.

3 Feb 2022

Ketamine is rapid, safe, and effective in treating hospitalized suicidal patients

Ketamine is a fast acting, efficient treatment for patients hospitalized for severe suicidal thoughts (ideation), finds a clinical trial published by The BMJ today.

3 Feb 2022

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

A randomized controlled trial assesses the efficacy and safety of high-dose convalescent plasma in the treatment of severe COVID-19.

1 Feb 2022

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according to findings published in Proceedings of the National Academy of Sciences.

1 Feb 2022

Placebo News and Research

Trial of early antiviral therapy for COVID-19 shows no significant benefit

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Two doses of psilocybin may ease depression symptoms for up to 12 months

New approach to alter the skin microbiome and reduce acne lesions using bacteria

Phase one study of oral SARS-CoV-2 antiviral agent nirmatrelvir

Individuals with alcohol problems may have lower functional connectivity in brain regions that process emotions

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Study examines whether viagra-like drug may be effective in treating vascular dementia

Reanalysis of the efficacy of COVID-19 vaccines

Paracetamol use increases blood pressure, study shows

Two peanut allergy treatments for children found to be highly effective at inducing remission

Colchicine holds promise to reduce the risk of severe COVID-19

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

Ketamine is rapid, safe, and effective in treating hospitalized suicidal patients

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Open-label placebo shows promise as therapy for disorders of gut-brain interaction in children

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study investigates how vitamin D or omega fatty acids may affect rates of autoimmune diseases

New trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News